 (BrJ Ophthalmol 1995; 79: 225-228) 
divided into two groups according to the depth of amblyopia before occlusion therapy was started: those with visual acuity between 20/60 and 20/100 and those with visual acuity of 20/100 or worse. Results-Deterioration of visual acuity was observed in 42% ofpatients in the first group and in 63% of patients in the second group. Their average deterioration, as measured by the Snellen chart, was 0 58 and 1-54 lines, respectively. The results were also assessed by the division of patients into three groups according to the type ofamblyopia: strabismic, strabismic anisometropic, and anisometropic. Deterioration of visual acuity occurred in 46%, 79%, and 36% of patients in these three groups, with an average deterioration on the Snelilen chart of 0-70, 2-04, and 0-64 lines, respectively. Conclusion-It is concluded that low initial visual acuity and strabismic anisometropic amblyopia are risk factors for deterioration of visual acuity in the long term, following the successful earlier treatment of eyes with amblyopia. (BrJ Ophthalmol 1995; 79: [225] [226] [227] [228] Occlusion of the good eye is the most widely accepted and probably the most effective method of treatment for amblyopia. After the treatment ends, however, the improved visual acuity in the amblyopic eye tends to deteriorate. In an earlier study,' we showed that visual deterioration had occurred in 55°/O of successfully treated eyes when measured at the long term follow up examination. We also found that the age at which treatment was started did not significantly affect the mean extent of deterioration or the mean visual acuity in the long term. In the present study we considered two additional variables as possible risk factors and examined their long term effects on the deterioration of visual acuity in eyes that had earlier been successfully treated for amblyopia: the initial depth of amblyopiathat is, the visual acuity of the amblyopic eye before the occlusive treatment was started, and the type of amblyopia. Inclusion of a patient in the present long term follow up study was contingent on the following criteria being met at the time that amblyopia was diagnosed and during the subsequent period of treatment and monitoring.
(1) Compliance of the child with an age suitable Snellen chart for the initial visual acuity examination. As an exception to this criterion there were 12 children with unilateral strabismus who were too young (under 3 years old) at the beginning of the study to be tested in this way. We estimated the visual acuity of the amblyopic eye in these children by determining the density of the filter required to induce a shift of fixation to the squinting or presumed amblyopic eye.
(2) An initial visual acuity of 20/60 or worse in the amblyopic eye.
(3) Full compliance with the instructions of the medical staff during the period of therapy and follow up.
(4) Cessation of occlusion therapy at least 1 year before the present study. 11 . We used this Snellen score rather than the logMAR score; we did so because throughout the study the visual acuity of the patients was determined by using Snellen charts rather than logMAR ones.
The visual acuity score at the long term follow up examination was compared with that attained by the child upon termination of occlusive therapy. The difference between them was the 'deterioration score', which reflects the amount of deterioration in visual acuity. For each of the groups defined above, the average amount of deterioration was calculated by dividing the sum of the deterioration scores by the number of children in the group.
The data for each child, including visual acuity before occlusion was started, refraction of both eyes However, the amount of deterioration at the long term follow up examination was significantly higher in the strabismic anisometropic group than in the strabismic group (p<0-01). Although the anisometropic group also showed less deterioration than the strabismic anisometropic group, the results are not statistically significant because of the small sample size.
Discussion
In our previous report,1 which included all of the patients in the present study, the long term results of occlusive treatment for amblyopia were analysed 6-4 years, on average, after the treatment was discontinued. We found that the visual acuity attained at the end of occlusive therapy was maintained in 45% of the successfully treated amblyopic eyes. This finding is in accordance with the results of other authors,2-8 who reported that 10-44% of treated eyes maintain their visual acuity at examinations performed 1-10 years after cessation of occlusive therapy. Our success rate was high because we included in our study only those children who had shown full compliance with the instructions of the medical staff during the period of therapy and the follow up.
In the previous study' we also found that the age at which therapy was initiated did not significantly affect the visual acuity results or the extent of deterioration of visual acuity measured at the long term follow up examination.
In the present study we analysed the influence of two additional variables, initial visual acuity and type of amblyopia, on the extent of long term deterioration of visual acuity in successfully treated eyes. We found that in children with an initial visual acuity of 20/100 or worse, the mean visual acuity achieved at the end of occlusive therapy was virtually identical with that of children with an initial visual acuity between 20/60 and 20/100. Thus, the depth of amblyopia before the start of occlusive therapy had little effect on the visual acuity results at the end of treatment. Thereafter, however, more children whose initial visual acuity was 20/100 or worse tended to deteriorate and the mean amount of deterioration in that group was greater than in children whose initial visual acuity was 20/60-20/100.
Ching and colleagues9 studied 116 strabismic patients with amblyopia treated by occlusion of the preferred eye. In 48% of their patients, amblyopia did not recur after cessation of occlusive therapy, while the rest required reinstitution of part time occlusion therapy because the amblyopia had recurred. The mean initial visual acuity before the start of treatment was found to have been significantly lower in the group that needed further treatment. Although the influence of the initial visual acuity on the long term visual acuity results was not evaluated in that study, the authors suggest that the more profoundly amblyopic patients should be followed more closely after therapy is discontinued, since they are at greater risk of developing recurrent amblyopia. In the present study we showed that in patients with deep amblyopia at the beginning of occlusion therapy, the visual acuity can be expected to deteriorate even years after discontinuation of therapy.
In order to evaluate the influence of different types of amblyopia on the long term visual acuity results, we defined three groups of patients according to the type of amblyopiathat is, strabismic, strabismic anisometropic, and anisometropic. We found a greater tendency towards deterioration of visual acuity in the strabismic anisometropic group; the mean deterioration in that group was about three times higher than in the other two groups. In a study of 89 patients treated for strabismic amblyopia and followed to at least 9 years of age, Scott and Flabetich Dickeyl' reported deterioration of visual acuity in 25% of the patients by the time they reached a mean age of 16 years. In our series, deterioration of visual acuity at the long term follow up examination was found in 46% of the patients with strabismic amblyopia. The difference between the two sets of results might be explained by the fact that in the former series only 19% of the patients had pretreatment visual acuity of 20/100 or worse, compared with 52% of the patients in our series. As mentioned above, patients with this low level of pretreatment visual acuity tend to show greater deterioration in visual acuity at the long term follow up examination.
Kutschke et al described visual acuity results in 124 children with anisometropic amblyopia."' Only 66 patients had completed occlusion therapy; of these, 16 (24%) subsequently regressed by two or more Snellen chart lines. The length of the follow up and the number of patients who regressed by only one line are not recorded. In our study, 14 children with anisometropic amblyopia were evaluated. Of these, five (36%) showed deterioration of visual acuity at the long term follow up examination. However, only three of these five children (21%) showed a deterioration of two or more Snellen chart lines.
Oster et al12 described a series in which 182 patients with amblyopia due to anisometropia, strabismus, or strabismic anisometropia were treated by primary occlusion. After termination of the occlusion therapy 85 patients (47%) maintained their visual acuity, while in 97 patients (53%) the visual acuity deteriorated and 'maintenance occlusion' had to be reinstituted. On the basis of the short term visual acuity results, the authors did not find any significant difference between the two groups with respect to the type of amblyopia.
The results of the present study indicate that low initial visual acuity and strabismic anisometropic amblyopia may significantly affect the long term of visual acuity results in eyes that earlier were successfully treated for amblyopia. We suggest that patients with these risk factors should be closely monitored for visual acuity up to the age of 9 years and repeatedly treated by patching whenever visual acuity shows deterioration.
